Paradoxical tuberculomas after completion of antituberculous treatment

Ira Shah1, Shilpa Borse

  • 1Pediatric TB Clinic, B. J. Wadia Hospital for Children, Mumbai, India.

Insights

Paradoxical reactions, a rare immune response to tuberculosis treatment, can manifest as intracranial tuberculomas even after completing antituberculous therapy (ATT). This study highlights two such cases in patients with tuberculous meningitis.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Tuberculous meningitis (TBM) is a severe form of tuberculosis affecting the central nervous system.
  • Paradoxical reactions (PRs) during anti-tuberculous therapy (ATT) are characterized by the worsening of existing lesions or the appearance of new ones.
  • PRs are typically attributed to an exaggerated host immune response to Mycobacterium tuberculosis antigens during ATT initiation.

Observation:

  • Paradoxical reactions in TBM commonly present as intracranial tuberculomas.
  • These reactions usually occur within 14-270 days of starting ATT, predominantly during the intensive phase of chemotherapy.
  • A rare subset of PRs occurs after the completion of ATT.

Findings:

  • This report details two cases of tuberculous meningitis where patients developed intracranial tuberculomas after completing their full course of ATT.
  • These cases represent rare instances of paradoxical reactions occurring late in the treatment course, post-ATT completion.
  • The development of tuberculomas post-ATT completion suggests a persistent or delayed immune response.

Implications:

  • The findings suggest that prolonged or delayed immune-mediated inflammation can occur even after successful completion of ATT for TBM.
  • Clinicians should maintain a high index of suspicion for paradoxical reactions, including late-onset tuberculomas, in patients with a history of TBM.
  • Further research is needed to understand the mechanisms behind late-onset paradoxical reactions and optimize management strategies.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations: